Does Blue Cross Blue Shield of Arizona Cover Cialis?

How BCBSAZ Formularies Handle Tadalafil and Cialis

Most Blue Cross Blue Shield of Arizona plans place generic tadalafil on their preferred formulary and either exclude brand-name Cialis entirely or list it as non-preferred with prior authorization requirements. The distinction matters because it determines your out-of-pocket cost and whether extra paperwork is needed before your pharmacy can fill the prescription.

Tadalafil received FDA approval in 2003 for erectile dysfunction, and the generic became available in September 2018 after Eli Lilly's patent exclusivity expired. Since then, most large insurers, BCBSAZ included, shifted coverage toward the generic formulation. According to an IQVIA report on generic drug access, generic substitution rates for drugs with available generics exceed 90% across major U.S. insurers.

BCBSAZ operates multiple plan types: HMO, PPO, EPO, and Medicare Advantage (Blue Cross MedicareRx). Each plan publishes its own formulary. On most commercial PPO and HMO formularies, generic tadalafil sits at Tier 2 (preferred generic) or Tier 3 (preferred brand), while brand Cialis is listed at Tier 4 (non-preferred) or excluded altogether. The practical result: a member filling generic tadalafil might pay $15-$40 per fill, while brand Cialis could cost $150-$300 as a non-preferred specialty copay, if the plan covers it at all.

Your specific plan's formulary is the final authority. BCBSAZ members can search their formulary online at the BCBSAZ member portal or call the number on the back of their insurance card to confirm tadalafil's tier placement before visiting a pharmacy.

Erectile Dysfunction vs. BPH: Why the Indication Changes Coverage

Tadalafil carries two distinct FDA-approved indications, and BCBSAZ treats them differently for coverage purposes. For erectile dysfunction (ED), tadalafil is prescribed as-needed at 10-20 mg doses. For benign prostatic hyperplasia (BPH), the approved dose is 5 mg daily.

This distinction is not arbitrary. The American Urological Association 2023 BPH guidelines list daily tadalafil 5 mg as a recommended option for lower urinary tract symptoms secondary to BPH. When prescribed for BPH, insurers often apply fewer quantity restrictions because the medication is used continuously rather than as-needed.

BCBSAZ commercial plans typically allow 30 tablets per month for the daily 5 mg BPH indication without prior authorization. For ED, quantity limits are stricter. Most plans cap as-needed tadalafil at 6 to 12 tablets per 30-day period. A prescriber who writes for tadalafil 5 mg daily with a BPH diagnosis code (ICD-10 N40.1) may encounter fewer coverage barriers than one prescribing 20 mg as-needed for ED (ICD-10 N52.9).

If your provider prescribes daily tadalafil and you have both ED and BPH symptoms, ask specifically which diagnosis code they plan to submit. The coding choice directly affects whether your BCBSAZ plan processes the claim under BPH or ED coverage rules.

Prior Authorization Requirements for Brand Cialis

When a BCBSAZ member or their prescriber requests brand-name Cialis instead of generic tadalafil, the plan almost always requires prior authorization (PA). This is a utilization management tool that insurers use to confirm medical necessity before covering a higher-cost medication.

The PA process for brand Cialis at BCBSAZ typically requires documentation of three things: a confirmed diagnosis, evidence that generic tadalafil was tried and failed or caused adverse effects, and a clinical rationale for why the brand formulation is medically necessary. According to a 2021 Kaiser Family Foundation analysis, over 30% of Part D formularies apply prior authorization to at least one PDE5 inhibitor.

Step therapy is the most common barrier. BCBSAZ formulary policies generally require a trial of generic tadalafil (and sometimes generic sildenafil) before approving brand Cialis. The required trial period is usually 30-90 days. If generic tadalafil causes documented side effects or proves ineffective at the maximum tolerated dose, the prescriber can submit a step therapy override request.

PA decisions are typically returned within 72 hours for standard requests and 24 hours for urgent requests. If denied, BCBSAZ members have the right to file an internal appeal within 180 days of the denial, followed by an external review through the Arizona Department of Insurance if the internal appeal is unsuccessful.

What Generic Tadalafil Costs on BCBSAZ Plans

Out-of-pocket costs for generic tadalafil vary substantially depending on your BCBSAZ plan type, tier placement, and whether you have met your deductible. Here is what members can generally expect across common plan structures.

On a typical BCBSAZ commercial PPO with generic tadalafil at Tier 2, the copay runs $10-$30 per fill for a 30-day supply. Tier 3 placement pushes that to $30-$50. Plans with coinsurance instead of flat copays may charge 20-35% of the drug's cost after the deductible is met, which for generic tadalafil (pharmacy acquisition cost roughly $30-$80 for 30 tablets of 20 mg) can mean $6-$28 out of pocket.

For BCBSAZ Medicare Advantage (Blue Cross MedicareRx) members, Part D coverage for ED medications is limited. Medicare Part D has historically excluded coverage for ED drugs, though some Medicare Advantage plans with enhanced benefits do include tadalafil. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D spending, effective January 2025, benefits members who do have Part D ED medication coverage by limiting total annual drug costs.

A study published in The Journal of Sexual Medicine found that the introduction of generic tadalafil reduced patient out-of-pocket spending on PDE5 inhibitors by 63-82% in the first year after generic availability. That price reduction is the primary reason BCBSAZ and other insurers shifted formulary preference toward the generic.

Members without tadalafil coverage, or those facing high copays, can compare pharmacy prices using discount programs. Cash-pay generic tadalafil through discount programs often runs $8-$30 for 30 tablets at major Arizona pharmacies, sometimes undercutting insurance copays.

How to Check Your Specific BCBSAZ Plan

Not all BCBSAZ plans are created the same way. An employer-sponsored PPO in Maricopa County may have a completely different formulary from an individual marketplace plan purchased through HealthCare.gov, even though both carry the Blue Cross Blue Shield of Arizona name.

Here are the concrete steps to verify your coverage. First, log into the BCBSAZ member portal and manage to "Find a Drug" or "Formulary Search." Enter "tadalafil" to see your plan's tier, quantity limits, and any PA or step therapy requirements. Second, if you cannot find this information online, call BCBSAZ member services at the number on your insurance card and ask three specific questions: Is generic tadalafil on my formulary? What tier is it? Are there quantity limits or prior authorization requirements?

Third, ask your prescriber's office to run a real-time pharmacy benefit check. Most electronic health record systems can query your specific plan's formulary and return tier, copay, PA status, and covered alternatives within seconds. This electronic verification is more reliable than formulary PDFs, which may be updated only quarterly.

For members on BCBSAZ plans obtained through the Arizona Health Insurance Marketplace, tadalafil coverage for ED is not mandated by the ACA essential health benefits package. States set their own benchmark plans for EHB, and Arizona's benchmark does not require ED medication coverage. Individual marketplace plans may or may not include it.

What to Do If BCBSAZ Denies Coverage

A denial does not have to be the final answer. BCBSAZ members have multiple pathways to obtain coverage for tadalafil or Cialis after an initial denial, and success rates for formulary exception appeals are higher than most patients realize.

The 2022 CMS Part D appeals data showed that approximately 60-75% of Part D coverage determination requests were decided in the enrollee's favor when the prescriber provided supporting clinical documentation. Commercial plan appeal success rates follow similar patterns when proper documentation accompanies the request.

Start with a formulary exception request. Your prescriber submits a letter to BCBSAZ explaining why the requested drug (brand or specific generic dose/quantity) is medically necessary for you. This letter should include your diagnosis, treatments already tried, documented side effects or treatment failures, and relevant clinical guidelines supporting the request.

If the internal appeal is denied, Arizona law allows you to request an external independent review. The Arizona Department of Insurance oversees this process. An external reviewer who is not affiliated with BCBSAZ evaluates the medical evidence and makes a binding decision.

Dr. Arthur Burnett, professor of urology at Johns Hopkins and lead author of the AUA guideline on erectile dysfunction, has stated: "PDE5 inhibitors remain first-line therapy for erectile dysfunction, and patients who fail one agent or formulation may respond to another. Access to the full range of available options is clinically important."

Alternatives If Cialis or Tadalafil Is Not Covered

If your BCBSAZ plan does not cover tadalafil at all, or if cost remains a barrier, several alternatives exist. Other PDE5 inhibitors may sit on a more favorable formulary tier. Generic sildenafil (the active ingredient in Viagra) is often Tier 1 or Tier 2 and costs $3-$15 per fill at many pharmacies. Generic vardenafil and generic avanafil are additional options, though avanafil tends to be more expensive.

The AUA erectile dysfunction guideline recommends PDE5 inhibitors as a class for first-line ED treatment and does not rank individual agents by preference, noting that efficacy and side effect profiles differ modestly between agents. A 2019 network meta-analysis published in the European Urology journal, analyzing 82 randomized trials with 47,626 participants, found that all four major PDE5 inhibitors (sildenafil, tadalafil, vardenafil, and avanafil) were significantly more effective than placebo for ED, with overlapping confidence intervals for efficacy.

Tadalafil's distinguishing feature is its 36-hour duration of action compared to 4-6 hours for sildenafil and vardenafil. If your preference for tadalafil is driven by this longer window, discuss it with your provider. That clinical rationale can strengthen a formulary exception request.

For patients who want tadalafil specifically, compounding pharmacies, manufacturer discount programs, and telehealth platforms like HealthRX offer direct-access pricing that may bypass insurance entirely. Cash-pay pricing for generic tadalafil has dropped significantly since 2018, making the out-of-pocket cost competitive with or lower than many insurance copays.

Arizona-Specific Insurance Regulations and ED Coverage

Arizona does not mandate that commercial health insurers cover erectile dysfunction medications. This is a state-by-state regulatory decision, and Arizona's insurance code does not include ED drugs in its list of required benefits.

The Arizona Department of Insurance and Financial Institutions regulates plan benefit designs for fully insured plans sold in the state. Self-funded employer plans (which cover the majority of commercially insured Arizonans) are regulated under federal ERISA law and are exempt from state mandates entirely. This means your employer's self-funded BCBSAZ plan could have different drug coverage rules than a fully insured BCBSAZ plan, even if both use the same pharmacy benefit manager.

For Arizona Medicaid (AHCCCS) members, erectile dysfunction medications have limited coverage. The Medicaid Drug Rebate Program requires state Medicaid programs to cover most FDA-approved drugs from manufacturers participating in the rebate program, but states can apply prior authorization and quantity limits. AHCCCS plans typically cover generic tadalafil with prior authorization for documented ED.

Arizona residents purchasing plans on the federal marketplace should review the Summary of Benefits and Coverage (SBC) document before enrollment to determine whether ED medications are included. This information is plan-specific and not standardized across marketplace offerings in the state.

When to Ask Your Provider About Switching

If your current BCBSAZ plan makes tadalafil too expensive or too difficult to obtain, a clinical conversation with your prescriber can open several doors. Switching to a covered alternative PDE5 inhibitor is the simplest path. Generic sildenafil 20 mg, originally approved as Revatio for pulmonary arterial hypertension, is sometimes prescribed off-label for ED at doses of 40-60 mg and may be covered under a different, more favorable formulary tier than sildenafil 25/50/100 mg tablets marketed for ED.

Your provider can also address underlying conditions that contribute to ED. The Endocrine Society's 2018 guidelines on testosterone therapy recommend measuring morning total testosterone in men with ED symptoms. If testosterone is below 300 ng/dL, testosterone replacement therapy may improve erectile function independently or enhance PDE5 inhibitor response. A trial of 790 men in the Testosterone Trials (TTrials) demonstrated that testosterone treatment for one year significantly improved sexual desire and erectile function compared to placebo in men with confirmed hypogonadism.

Patients with ED related to cardiovascular risk factors, diabetes, or obesity may also benefit from GLP-1 receptor agonists. A 2024 post-hoc analysis of the SELECT trial (N=17,604) published in the Journal of the American College of Cardiology found that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in adults with obesity, and improved metabolic parameters known to contribute to vascular-mediated ED.

The right medication depends on your specific clinical picture, and a formulary barrier should prompt a broader treatment discussion rather than simply abandoning the prescription.